{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 56,
        "end": 67
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 70,
        "end": 81
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 86,
        "end": 98
      }
    },
    {
      "id": "T4",
      "obj": "Disease",
      "span": {
        "begin": 112,
        "end": 129
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 159,
        "end": 166
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 169,
        "end": 172
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 179,
        "end": 184
      }
    },
    {
      "id": "T11",
      "obj": "Chemical",
      "span": {
        "begin": 254,
        "end": 266
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23792648_11",
  "text": "Our findings indicate the growth suppressive effects of doxorubicin , oxaliplatin and methotrexate treatment on stomach carcinoma cells and the implication of BCL2L12 , BAX , and BCL-2 expression profiles in the molecular signaling pathways triggered by chemotherapy ."
}
